GLYDAY MET 1000 TABLET is a combination of Metformin and Vildagliptin which belongs to a group of medicines called Antidiabetic agents. GLYDAY MET 1000 TABLET is used to treat type 2 diabetes (also known as non-insulin dependent diabetes mellitus) in adult patients, whose diabetes cannot be controlled by diet and exercise alone and/or with other medicines used to treat diabetes (insulin or sulphonylureas such as glimepiride, glipizide). Type 2 diabetes is a chronic medical condition in which the body does not make enough insulin, or the produced insulin does not work well. Symptoms include excessive urination, excessive thirst, hunger, fatigue, and blurred vision.
Metformin decreases hepatic glucose production and intestinal absorption of glucose and improves insulin sensitivity (increases peripheral glucose uptake and utilization). Vildagliptin works by making the pancreas produce more insulin and less glucagon, thus leading to a decrease in blood glucose levels. Along treatment with GLYDAY MET 1000 TABLET, follow regular exercise and diet plan as advised by your doctor to achieve better results.
Before taking GLYDAY MET 1000 TABLET inform your doctor if you have liver, kidney, or heart problems. It should be used during pregnancy only if advised by your doctor and not recommended for use in breast-feeding women. GLYDAY MET 1000 TABLET is not suitable for use in children and adolescents under 18 years of age and it should be used with caution in elderly patients (65 years of age and above). Avoid consumption of alcohol during treatment with GLYDAY MET 1000 TABLET as it may increase the risk of lactic acidosis. The most common side effects of taking GLYDAY MET 1000 TABLET are nausea, vomiting, stomach pain, headache, low blood sugar and diarrhoea. Contact your doctor if any of the symptoms worsen.
GLYDAY MET 1000 TABLET helps to control the level of sugar in the blood, where metformin works by helping the body to make better use of insulin and vildagliptin works by making the pancreas produce more insulin and less glucagon.
Always take GLYDAY MET 1000 TABLET as directed by your physician. Take this medicine with or just after the food, swallow the medicine as a whole and do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon age and health condition. Do not stop taking GLYDAY MET 1000 TABLET without informing your doctor.
Stop taking GLYDAY MET 1000 TABLET and contact your doctor immediately if you experience any of the following side effects:
Take fiber rich foods in your diet such as fresh fruits, vegetables and whole grain cereals, and drink plenty of fluids. Exercise more regularly and stay active. Consult your doctor if the symptom did not improve.
Drink lots of fluids, such as water or fruit juices to keep yourself hydrated. Avoid taking any medicine on your own for treating diarrhea. Consult your doctor if the symptom did not improve.
Rest and relax. Drink sufficient amount of fluids such as water. Apply a pain-relieving balm on the head if required. Consult your doctor if the symptom did not improve.
Stick to simple meals. Avoid eating oily, fried, or spicy food. Do not perform any strenuous activities immediately after eating. Consult your doctor if the symptom did not improve.
Rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heat pad on your stomach. Do not self-treat on your own and consult your doctor if the symptom did not improve on its own.
GLYDAY MET 1000 TABLET is generally not recommended for use in pregnant women unless it is considered clearly necessary. Consult your doctor before taking GLYDAY MET 1000 TABLET.
GLYDAY MET 1000 TABLET is not recommended for use in breastfeeding women. Consult your doctor before taking GLYDAY MET 1000 TABLET.
Do not drive or operate any machines if you experience dizziness after taking GLYDAY MET 1000 TABLET.
Consumption of alcohol is not recommended during treatment with GLYDAY MET 1000 TABLET since it may increase the risk of lactic acidosis.
GLYDAY MET 1000 TABLET is not recommended in patients with severely reduced kidney function. Consult your doctor before taking GLYDAY MET 1000 TABLET.
GLYDAY MET 1000 TABLET is not recommended in patients with liver disease. Consult your doctor before taking GLYDAY MET 1000 TABLET.
Do not take GLYDAY MET 1000 TABLET if you are allergic (hypersensitive) to Metformin or Vildagliptin.
GLYDAY MET 1000 TABLET is not recommended in patients who recently had heart attack or heart failure or any signs of heart problems such as serious problems with blood circulation or difficulty in breathing. Consult your doctor before taking GLYDAY MET 1000 TABLET.
GLYDAY MET 1000 TABLET is not recommended for use in children and adolescents less than 18 years of age due to lack of safety and effectiveness. Consult with your doctor for advice.
GLYDAY MET 1000 TABLET should be used with caution in elderly patients above 65 years of age, especially in patients with impaired kidney function. Your doctor will adjust the dose depending upon kidney function and your kidney function will be monitored regularly. Consult with your doctor before taking GLYDAY MET 1000 TABLET.
GLYDAY MET 1000 TABLET is not recommended for you, if you have:
Before taking GLYDAY MET 1000 TABLET, inform your doctor if you have or had:
A. Drug-Drug interactions:
Before taking GLYDAY MET 1000 TABLET inform to your doctor, if you are taking any of these medicines:
Overdosage:
If you or anyone else accidentally take too much of GLYDAY MET 1000 TABLET, consult your doctor immediately. Overdosage symptoms of GLYDAY MET 1000 TABLET might include low blood sugar levels, lactic acidosis, muscle pain, mild and transient burning or tickling sensation in body, fever, and edema.
Drug | : | Metformin and Vildagliptin |
Pharmacological Category | : | Antidiabetic agent (Biguanides & Dipeptidyl Peptidase 4 Inhibitor) |
Therapeutic Indication | : | Type 2 Diabetes mellitus |
Dosage Forms | : | Tablet |
Q: What is GLYDAY MET 1000 TABLET used for?
A: GLYDAY MET 1000 TABLET is used to treat type 2 diabetes (also known as non-insulin dependent diabetes mellitus) in adult patients, whose diabetes cannot be controlled by diet and exercise alone and/or with other medicines used to treat diabetes (insulin or sulphonylureas such as glimepiride, glipizide).
Q: Can GLYDAY MET 1000 TABLET be used in elderly patients?
A: GLYDAY MET 1000 TABLET should be used with caution in elderly patients above 65 years of age, especially in patients with impaired kidney function. Your doctor will adjust the dose depending upon kidney function and your kidney function will be monitored regularly. Consult with your doctor before taking GLYDAY MET 1000 TABLET.
Q: Is GLYDAY MET 1000 TABLET safe to use in patients with heart problems?
A: GLYDAY MET 1000 TABLET is not recommended in patients who recently had heart attack or heart failure or any signs of heart problems such as serious problems with blood circulation or difficulty in breathing. Consult your doctor before taking GLYDAY MET 1000 TABLET.
Q: What are the most common side effects of taking GLYDAY MET 1000 TABLET?
A: The most common side effects of taking GLYDAY MET 1000 TABLET are nausea, vomiting, stomach pain, headache, dizziness, loss of appetite, metallic taste, uncontrolled trembling, low blood sugar and diarrhoea. Contact your doctor if any of the symptoms worsen.
Q: Can I consume alcohol while taking GLYDAY MET 1000 TABLET?
A: Consumption of alcohol is not recommended during treatment with GLYDAY MET 1000 TABLET since it may increase the risk of lactic acidosis. Consult your doctor before taking GLYDAY MET 1000 TABLET if you are alcoholic or with history of alcoholism.
1. KD Tripathi MD. Hormones and related drugs. Essentials of Medical Pharmacology. Seventh edition. New Delhi, May 2013. Page – 274.
2. Paresh Ved and Samrat Shah. Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus. March 2012. [Accessed on 30th June 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354946/
3. Serge Halimi, Anja Schweizer, Biljana Minic, James Foley and Sylvie Dejage. Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet. March 2008. [Accessed on 30th June 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515409/
4. Novartis Pharma GmbH. Electronic Medicines Compendium (EMC) [Revised in August 2021] [Accessed on 30th June 2021] https://www.medicines.org.uk/emc/files/pil.6226.pdf
5. Cipla Ltd. VYSOV-M Tablets (Vildagliptin + Metformin hydrochloride). [Revised in July 2020] [Accessed on June 30, 2021] https://ciplamed.com/print-product-pdf/37162
Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 28 Feb 2023 | 09:49 AM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.